Found: 7
Select item for more details and to access through your institution.
Bedaquiline Resistance after Effective Treatment of Multidrug-Resistant Tuberculosis, Namibia.
- Published in:
- Emerging Infectious Diseases, 2024, v. 30, n. 3, p. 568, doi. 10.3201/eid3003.240134
- By:
- Publication type:
- Article
Case-Finding Strategies for Drug-Resistant Tuberculosis:Protocol for a Scoping Review.
- Published in:
- JMIR Research Protocols, 2022, v. 11, n. 12, p. 1, doi. 10.2196/40009
- By:
- Publication type:
- Article
Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia.
- Published in:
- Patient Preference & Adherence, 2016, v. 10, p. 2369, doi. 10.2147/PPA.S116860
- By:
- Publication type:
- Article
Comparing amikacin and kanamycininduced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort.
- Published in:
- BMC Pharmacology & Toxicology, 2015, v. 16, p. 1, doi. 10.1186/s40360-015-0036-7
- By:
- Publication type:
- Article
Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study.
- Published in:
- Journal of Pharmaceutical Policy & Practice, 2014, v. 7, n. 10, p. 7, doi. 10.1186/2052-3211-7-14
- By:
- Publication type:
- Article
Adverse Events During Treatment of Drug-Resistant Tuberculosis: A Comparison Between Patients With or Without Human Immunodeficiency Virus Co-infection.
- Published in:
- Drug Safety, 2013, v. 36, n. 11, p. 1087, doi. 10.1007/s40264-013-0091-1
- By:
- Publication type:
- Article
The burden of adverse events during treatment of drug-resistant tuberculosis in Namibia.
- Published in:
- Southern Med Review, 2012, v. 5, n. 1, p. 6
- By:
- Publication type:
- Article